Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Visible Genetics Inc.(VGIN) -- Ignore unavailable to you. Want to Upgrade?

To: Robert G. Hanah who wrote (269)	2/11/1999 10:35:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 337

Yes, Bob, we know all of that. Thanks. What do you think about the last financing? And, at $100/share, what do you think about the capitalization relative to competitors? BTW..... is Murex working on a follow-on project, and, now that they're no longer an independent biotech, what are our chances of following the work? How are the margins on the sequencers going? Any improvement? Is the HLA system selling? What's the next source of cash going to be? What is the option ass'd with the Roche license? This company made $20/share on the back of hard work by VGIN employees, a whim, and a prayer. The price:book is 40. Do you care about stuff like that, or just about sticking the next guy? Either style of investing is fine by me. You play the game, you take your chances. However, this thread has been a repository of information relating to business success and scientific achievements. It serves a purpose, and I'd prefer that you start a new thread rather than attempt to change that purpose. Thanks, Rick